Madrigal shareholders elect three Class III directors, ratify PwC, approve say-on-pay

MADRIGAL PHARMACEUTICALS, INC.

Class III directors elected: Gollust 9.6M for/2.2M withheld, Levy 10.5M/1.3M, Milligan 11.6M/116K.
Ratification of PricewaterhouseCoopers as auditor: 14.7M for, 19.8K against, 51K abstain.
Advisory vote on executive compensation: 11.6M for, 111.9K against (99.0% of votes cast).
Quorum of 14.78M shares present out of 17.10M outstanding as of April 27, 2022 record date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.